Regulus Therapeutics Presents Additional Data from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program at PKD Connect 2021 ...Middle East

SAN DIEGO, June 25, 2021 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced the presentation of additional data from the...

Hence then, the article about regulus therapeutics presents additional data from its autosomal dominant polycystic kidney disease adpkd program at pkd connect 2021 was published today ( Friday 25/06/2021 - 02:16 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Regulus Therapeutics Presents Additional Data from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program at PKD Connect 2021 )

Also on site :

• Hundreds of flights delayed at O'Hare after pipe burst at air traffic control tower
• Humans&, a ‘human-centric’ AI startup founded by Anthropic, xAI, Google alums, raised $480M seed round
• Karamo Brown Skips 'Queer Eye' Interviews and Says He Felt 'Mentally and Emotionally Abused' for Years